Cargando…

p16 (INK4a) and the Alveolar Niche Take Center Stage in Bronchopulmonary Dysplasia

Detalles Bibliográficos
Autores principales:	Chao, Cho-Ming, Bellusci, Saverio, Zepp, Jarod A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2020
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560801/ https://www.ncbi.nlm.nih.gov/pubmed/32668168 http://dx.doi.org/10.1164/rccm.202006-2164ED

Ejemplares similares

Pathogenesis of bronchopulmonary dysplasia: when inflammation meets organ development
por: Shahzad, Tayyab, et al.
Publicado: (2016)

Stem/Progenitor Cells and Related Therapy in Bronchopulmonary Dysplasia
por: Marega, Manuela, et al.
Publicado: (2023)

A Breath of Fresh Air on the Mesenchyme: Impact of Impaired Mesenchymal Development on the Pathogenesis of Bronchopulmonary Dysplasia
por: Chao, Cho-Ming, et al.
Publicado: (2015)

FGF10 Triggers De Novo Alveologenesis in a Bronchopulmonary Dysplasia Model: Impact on Resident Mesenchymal Niche Cells
por: Taghizadeh, Sara, et al.
Publicado: (2022)

Targeting Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH): Potential Role of the FGF Signaling Pathway in the Development of the Pulmonary Vascular System †
por: Chao, Cho-Ming, et al.
Publicado: (2020)

When inflammation meets lung development—an update on the pathogenesis of bronchopulmonary dysplasia
por: Holzfurtner, Lena, et al.
Publicado: (2022)

NOVEL BIOMARKERS OF BRONCHOPULMONARY DYSPLASIA AND BRONCHOPULMONARY DYSPLASIA-ASSOCIATED PULMONARY HYPERTENSION
por: Sahni, Mitali, et al.
Publicado: (2020)

Phenotypes of Bronchopulmonary Dysplasia
por: Wang, Shih-Hsin, et al.
Publicado: (2020)

Tissue-Resident Type 2 Innate Lymphoid Cells Arrest Alveolarization in Bronchopulmonary Dysplasia
por: Mi, Lanlan, et al.
Publicado: (2020)

Editorial: Bronchopulmonary dysplasia: latest advances
por: Perveen, Shahana, et al.
Publicado: (2023)

A semi-automated method for unbiased alveolar morphometry: Validation in a bronchopulmonary dysplasia model
por: Salaets, Thomas, et al.
Publicado: (2020)

Pulmonary Biomarkers of Bronchopulmonary Dysplasia
por: Thompson, Alecia, et al.
Publicado: (2008)

Incidence of Bronchopulmonary Dysplasia in Korea
por: Choi, Chang Won, et al.
Publicado: (2012)

Oxidative Stress and Bronchopulmonary Dysplasia
por: Perrone, Serafina, et al.
Publicado: (2012)

Present and Future of Bronchopulmonary Dysplasia
por: Bonadies, Luca, et al.
Publicado: (2020)

Perspectives on Probiotics and Bronchopulmonary Dysplasia
por: Yang, Kun, et al.
Publicado: (2020)

Pulmonary hypertension in bronchopulmonary dysplasia
por: Hansmann, Georg, et al.
Publicado: (2020)

Bronchopulmonary Dysplasia: Pathogenesis and Pathophysiology
por: Dankhara, Nilesh, et al.
Publicado: (2023)

Lung epithelial stem cells and their niches: Fgf10 takes center stage
por: Volckaert, Thomas, et al.
Publicado: (2014)

Cerebral Myelination in a Bronchopulmonary Dysplasia Murine Model
por: Chen, Wenwen, et al.
Publicado: (2023)

The Role of Insulin Receptor Substrate Proteins in Bronchopulmonary Dysplasia and Asthma: New Potential Perspectives
por: Gorgisen, Gokhan, et al.
Publicado: (2022)

Pulmonary hypertension in infants with bronchopulmonary dysplasia
por: Kim, Gi Beom
Publicado: (2010)

Pulmonary Hemosiderosis in Children with Bronchopulmonary Dysplasia
por: Kurahara, David, et al.
Publicado: (2014)

Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant
por: Rivera, Lidys, et al.
Publicado: (2016)

Hospital management of severe bronchopulmonary dysplasia
por: Moretti, Corrado, et al.
Publicado: (2015)

Correlation of Retinopathy of Prematurity with Bronchopulmonary Dysplasia
por: Podraza, Wojciech, et al.
Publicado: (2018)

The rate and pattern of bronchopulmonary dysplasia in Kuwait
por: Al-Essa, Mazen, et al.
Publicado: (2004)

Impact of bronchopulmonary dysplasia on brain and retina
por: Poon, Annie Wing Hoi, et al.
Publicado: (2016)

Strategies to improve outcomes of bronchopulmonary dysplasia
por: Jung, Young Hwa, et al.
Publicado: (2019)

New Pharmacologic Approaches to Bronchopulmonary Dysplasia
por: Roberts, Katelyn, et al.
Publicado: (2021)

An Update on the Prevention and Management of Bronchopulmonary Dysplasia
por: Hennelly, Marissa, et al.
Publicado: (2021)

Patho-mechanisms of the origins of bronchopulmonary dysplasia
por: Sahni, Mitali, et al.
Publicado: (2021)

Pharmacotherapy in Bronchopulmonary Dysplasia: What Is the Evidence?
por: Sakaria, Rishika P., et al.
Publicado: (2022)

Bronchodilator responsiveness and dysanapsis in bronchopulmonary dysplasia
por: Nelin, Leif D., et al.
Publicado: (2022)

Development and Disorders of the Airway in Bronchopulmonary Dysplasia
por: Bush, Douglas, et al.
Publicado: (2023)

Erratum: Perinatal Hypoxia-Inducible Factor Stabilization Preserves Lung Alveolar and Vascular Growth in Experimental Bronchopulmonary Dysplasia
Publicado: (2023)

Refining anti‐inflammatory therapy strategies for bronchopulmonary dysplasia
por: Rudloff, Ina, et al.
Publicado: (2016)

Pulmonary Hypertension in Preterm Infants With Bronchopulmonary Dysplasia
por: An, Hyo Soon, et al.
Publicado: (2010)

Nutrition of preterm infants in relation to bronchopulmonary dysplasia
por: Wemhöner, Andreas, et al.
Publicado: (2011)

Utilization of Inhaled Corticosteroids for Infants with Bronchopulmonary Dysplasia
por: Slaughter, Jonathan L., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_lmmq47uj9mrmn59msig96op877